SeaSpine Corporation

NASDAQ: SPNE · Real-Time Price · USD
9.54
0.73 (8.29%)
At close: Jan 04, 2023, 10:00 PM

Company Description

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally.

It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine.

The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.

It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM.

In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine.

SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

SeaSpine Corporation
SeaSpine  Corporation logo
Country United States
IPO Date Jun 17, 2015
Industry Medical - Devices
Sector Healthcare
Employees 523
CEO Keith C. Valentine

Contact Details

Address:
5770 Armada Drive
Carlsbad, California
United States
Website https://www.seaspine.com

Stock Details

Ticker Symbol SPNE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001637761
CUSIP Number 81255T108
ISIN Number US81255T1088
Employer ID 47-3251758
SIC Code 3841

Key Executives

Name Position
Keith C. Valentine Pres, Chief Executive Officer & Director
John J. Bostjancic Senior Vice President, Chief Financial Officer, Chief Operating Officer & Treasurer
Carrie Mendivil Head of Investor Relations
Dennis L. Cirino Senior Vice President of Global Spinal Systems
Dr. Beau Standish P.Eng., Ph.D. Pres of Enabling Technologies
Dr. Frank Vizesi Chief Scientific Officer
Hollis Winkler Senior Vice President of HR
John J. Winge Vice President of Sales
Patrick L. Keran J.D. Senior Vice President, Gen. Counsel & Sec.
Tyler P. Lipschultz Senior Vice President of Orthobiologics & Bus. Devel.

Latest SEC Filings

Date Type Title
Apr 03, 2023 CT ORDER Filing
Jan 31, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jan 17, 2023 15-12G Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing
Jan 09, 2023 4 Filing